CRACK-TARGET 1: Descriptive Study of Observed Behavioral Sensitization and Expectations

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorAssistance Publique - Hôpitaux de Paris

About this trial

This research focuses on behavioral sensitization (BS) a specific behavioural disturbance in crack-cocaine addiction. The primary objective is to observe whether BS can be demonstrated in an ecological setting in crack dependent users by continuous actimetry for 3 weeks.

It is planned to include 20 persons with a current crack-cocaine addiction with a preferential use of rapid administration route (intravenous or smoke), in a care institution: Fernand Widal Hospital.

In the proposed research, the investigators will assess the movements of crack-cocaine dependent users in relation to consumption. They will have to wear continuously for 3 weeks an actimeter. They will also have 3 blood tests trying to identify biomarkers of BS.

Eligibility criteria

Qualifiers

> 18 years

Have a current crack-cocaine use disorder defined as Severe Intensity Use Disorder (6 or more DSM5 criteria), AND preferential use of rapid administration route (intravenous or smoked)

Self-identified male or female (n=10 males, n=10 females)

Negative pregnancy test for females and use of effective contraception

Disqualifiers

• Patient with a psychiatric disorder or symptoms that are not currently stabilized

Patient who is a minor or under protective supervision (curatorship or guardianship)

Patient in care at the request of a judicial authority (therapeutic injunction, classification with orientation)

Pregnant or breastfeeding women

Trial design

Treatments tested in this trial

  • Observation of behavior and search of biomarkers with 3 blood tests.3 weeks wearing an actimeter
  • 3 blood tests

Treatment groups

20 Participants
are divided into 1 treatment group

Sponsors and collaborators

Assistance Publique - Hôpitaux de Paris

Lead sponsor

Institut National de la Santé Et de la Recherche Médicale, France

Collaborator